Market Intelligence for the Medical Cannabis Industry
Information, Data & Insight Drive Better Decisions.
CSEQUENCE is a market intelligence company in the medical cannabis space. Cannabis is medicine and our goal is to bridge the gap between research and effective use. We do this through three areas: education, market research, and events.
“We feel that we can support this community by helping manufacturers make informed decisions to help them identify opportunities, avoid pitfalls and ultimately serve the patients who can benefit from their products.”
“I have spent nearly half of my life working with issues related to data, information and insight for clients in the healthcare sector. The work that I have done has helped clients launch products, identify potential opportunities and avoid pitfalls in a dynamic industry. For us, working in healthcare has been particularly rewarding because we know that if we do our job well, it will directly translate to benefits for the patient.
It is this desire to help the patient that is at the heart of the work we are doing in the cannabis derived medicine market. The growing body of real-world evidence regarding the potential power of cannabis-derived medicines to treat a variety of ailments (e.g. pain, sleeplessness, anxiety) is undeniable. Interest from investors, regulators, manufacturers, ancillary service providers and consumers is pouring in creating a rapidly expanding and dynamic industry.
We feel that we can support this community by helping manufacturers make informed decisions to help them identify opportunities, avoid pitfalls and ultimately serve the patients who can benefit from their products.
Csequence is the next step in the evolution of data-based decision-making.”
Founder of Csequence